Summary

Spotify founder Daniel Ek’s body-scanning startup, Neko Health, is setting its sights on the United States after raising 700 million and plans to open its first clinic in New York this year. Neko Health just raised 700 million and plans to open its first clinic in New York this year. ![Neko Health - Founders - Hjalmar Nilsonne & Daniel Ek (landscape)](https://platform.theverge.com/wp-content/uploads/sites/2/2026/07/Neko-Health-Founders-Hjalmar-Nilsonne-Daniel-Ek-landscape.jpeg?quality=90&strip=all&crop=0.01355748373102%2C0%2C99.972885032538%2C100&w=2400) ![Neko Health - Founders - Hjalmar Nilsonne & Daniel Ek (landscape)](https://platform.theverge.com/wp-content/uploads/sites/2/2026/07/Neko-Health-Founders-Hjalmar-Nilsonne-Daniel-Ek-landscape.jpeg?quality=90&strip=all&crop=0.01355748373102%2C0%2C99.972885032538%2C100&w=2400) Neko operates private clinics offering full-body scans and blood tests using AI and custom-built medical equipment. Scans are designed to proactively screen customers for conditions including skin cancer, heart disease, and diabetes. The company says its goal is to catch problems early, prevent disease, and help people live longer. In a [press release](https://www.nekohealth.com/gb/en/press/neko-health-raises-usd700m-series-c-ahead-of-us-launch), cofounder and CEO Hjalmar Nilsonne said the new funding will help Neko take “that mission to the US for the first time,” starting with New York and other cities this year. The company did not specify where else it plans to open clinics or provide a more detailed timeline, though a waitlist for the [New York location](https://www.nekohealth.com/us/en/locations/nyc/nyc) is now open on its website. The money will also fund further research and development into technology Nilsonne said could “make prevention possible at scale.” Neko, which was founded in 2018 but operated quietly [until launching in 2023](/2023/2/4/23585948/spotify-founder-daniel-ek-ai-body-health-scanner), is part of a growing cohort of companies focused on preventive care and private screening, a market driven in part by rising interest in longevity and [biohacking](/column/963917/optimizer-bryan-johnson-biohacking-health) and gaps in traditional healthcare systems that are often more reactive, intervening only after symptoms appear. According to its website, Neko currently operates eight clinics in the UK and Sweden, including four in London and two in Stockholm. Scans cost £299 in the UK and 2,750 Swedish kronor in Sweden — roughly 400 and 7 billion. The company last raised $260 million in early 2025. Most Popular

  • The OLED Xbox Ally X20 is so good, Asus will sell it solo
  • Plex problems prevented users from streaming movies and shows
  • Siri AI is already changing how I use my iPhone
  • This free Mac app reveals the truth about your mystery USB-C cables
  • SpaceXAI’s Grok programming tool was uploading its users’ entire codebase to cloud storage

By Robert Hart

Original Article